Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Chagriya, Kitiyakara"'
Autor:
Sakulrat Mankhong, Thittaya Den-Udom, Tanotnon Tanawattanasuntorn, Thunwarat Suriyun, Kenjiro Muta, Chagriya Kitiyakara, Pimonrat Ketsawatsomkron
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Increased protein-bound uremic toxins (PBUTs) in patients with chronic kidney disease (CKD) are associated with cardiovascular diseases (CVDs); however, whether retention of PBUTs causes CVD remains unclear. Previous studies assessing the im
Externí odkaz:
https://doaj.org/article/8bf9274c8db14364962a1926b08c4a8c
Autor:
Alongkorn Kurilung, Suphitcha Limjiasahapong, Khwanta Kaewnarin, Pattipong Wisanpitayakorn, Narumol Jariyasopit, Kwanjeera Wanichthanarak, Sitanan Sartyoungkul, Stephen Choong Chee Wong, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara, Yongyut Sirivatanauksorn, Sakda Khoomrung
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 5, Pp 100921- (2024)
The collision cross-sections (CCS) measurement using ion mobility spectrometry (IMS) in combination with mass spectrometry (MS) offers a great opportunity to increase confidence in metabolite identification. However, owing to the lack of sensitivity
Externí odkaz:
https://doaj.org/article/10d5298666ff43ed96a68bafe5615f68
Autor:
Chitimaporn Janphram, Suchin Worawichawong, Montira Assanatham, Arkom Nongnuch, Sansanee Thotsiri, Umaporn Udomsubpayakul, Surangkana Wimolluck, Naparada Poomjun, Atiporn Ingsathit, Sinee Disthabanchong, Vasant Sumethkul, Wichai Aekplakorn, Panas Chalermsanyakorn, Chagriya Kitiyakara
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Death and end-stage kidney disease (ESKD) are major outcomes of glomerular disease. (GD) The years of potential life lost (YLL) may provide additional insight into the disease burden beyond death rates. There is limited data on premature mor
Externí odkaz:
https://doaj.org/article/51bd135ff0254a4aa1e307c96df472fc
Autor:
Praopilad Srisuwarn, Napun Sutharattanapong, Sinee Disthabanchong, Surasak Kantachuvesiri, Chagriya Kitiyakara, Bunyong Phakdeekitcharoen, Atiporn Ingsathit, Vasant Sumethkul
Publikováno v:
Transplant International, Vol 37 (2024)
Kidney transplant recipients (KTRs) are at increased risk of developing de novo post-transplant malignancies (PTMs), with regional differences in types with excess risk compared to the general population. A single-center, population-controlled, retro
Externí odkaz:
https://doaj.org/article/b13e24140eab485688a81b8c57f93565
Autor:
Wichai Aekplakorn, Suwat Chariyalertsak, Pattapong Kessomboon, Sawitri Assanangkornchai, Surasak Taneepanichskul, Nareemarn Neelapaichit, Anchalee Chittamma, Chagriya Kitiyakara
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract There are limited data on chronic kidney disease of unknown etiology (CKDu) from Southeast Asia. Initially described in working age men, a common approach to detect CKDu that includes all adults has recently been proposed. We determined the
Externí odkaz:
https://doaj.org/article/3cf5832e5a024fd29a8b226572b18019
Autor:
Pornpen Sangthawan, Pinkaew Klyprayong, Sarayut L. Geater, Pimwara Tanvejsilp, Sirirat Anutrakulchai, Sarinya Boongird, Pongsathorn Gojaseni, Charan Kuhiran, Pichet Lorvinitnun, Kajohnsak Noppakun, Watanyu Parapiboon, Supinda Sirilak, Pluemjit Tankee, Puntapong Taruangsri, Pasuree Sangsupawanich, Piyamitr Sritara, Nathorn Chaiyakunapruk, Chagriya Kitiyakara
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
ObjectiveUniversal health coverage can decrease the magnitude of the individual patient's financial burden of chronic kidney disease (CKD), but the residual financial hardship from the patients' perspective has not been well-studied in low and middle
Externí odkaz:
https://doaj.org/article/c42ddc08796e4e359685355ee8f48aaa
Autor:
Nattayaporn Apaijai, Sirawit Sriwichaiin, Arintaya Phrommintikul, Thidarat Jaiwongkam, Sasiwan Kerdphoo, Sirintorn Chansirikarnjana, Nisakron Thongmung, Usanee Mahantassanapong, Prin Vathesatogkit, Chagriya Kitiyakara, Piyamitr Sritara, Nipon Chattipakorn, Siriporn C. Chattipakorn
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Cognitive impairment is commonly found in the elderly population. Evidence suggests that mitochondrial function in lymphocytes are potential biomarkers in the progression of neurodegeneration, as peripheral mitochondrial function is associat
Externí odkaz:
https://doaj.org/article/1fbc18d9edd34140bd2561d3a3857412
Autor:
Sarassawan Kananuraks, Montira Assanatham, Sarinya Boongird, Chagriya Kitiyakara, Kanin Thammavaranucupt, Thosaphol Limpijarnkij, Daruneewan Warodomwichit, Andrew Davenport, Arkom Nongnuch
Publikováno v:
Kidney International Reports, Vol 5, Iss 9, Pp 1495-1502 (2020)
Introduction: Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to de
Externí odkaz:
https://doaj.org/article/bea0a44f0a6540838a9e5c71d0d3a939
Autor:
Pintip Ngamjanyaporn, Suchin Worawichawong, Prapaporn Pisitkun, Khantong Khiewngam, Surasak Kantachuvesiri, Arkom Nongnuch, Montira Assanatham, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Introduction There is a need for sensitive and specific biomarkers to predict kidney damage and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP-1) and epidermal growth factor (EGF) are cytokines with divergent ro
Externí odkaz:
https://doaj.org/article/e0de1dd3971347d8b66f8e9925e1e9c6
Autor:
Krittima Anekthanakul, Siriphan Manocheewa, Kittiphan Chienwichai, Patcha Poungsombat, Suphitcha Limjiasahapong, Kwanjeera Wanichthanarak, Narumol Jariyasopit, Vivek Bhakta Mathema, Chutima Kuhakarn, Vichai Reutrakul, Jutarop Phetcharaburanin, Atikorn Panya, Natthaporn Phonsatta, Wonnop Visessanguan, Yotsawat Pomyen, Yongyut Sirivatanauksorn, Suchin Worawichawong, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara, Sakda Khoomrung
Publikováno v:
iScience, Vol 24, Iss 11, Pp 103355- (2021)
Summary: The current gold standard for classifying lupus nephritis (LN) progression is a renal biopsy, which is an invasive procedure. Undergoing a series of biopsies for monitoring disease progression and treatments is unlikely suitable for patients
Externí odkaz:
https://doaj.org/article/b6ff70646f9e450cb64fa3de0377b6fc